OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert ABBV.../  DE000ME6VEA4  /

Stuttgart
5/17/2024  6:46:52 PM Chg.+1.98 Bid10:00:35 PM Ask10:00:35 PM Underlying Strike price Expiration date Option type
150.97EUR +1.33% -
Bid Size: -		 -
Ask Size: -		 AbbVie Inc - USD 6/28/2024 Call
GlobeNewswire 1:12 PM INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire 5/16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 5/16 Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
GlobeNewswire 5/14 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire 5/14 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 5/14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 5/14 In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit
GlobeNewswire 5/13 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 5/11 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC
GlobeNewswire 5/9 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 5/9 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 5/9 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 5/9 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire 5/8 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 5/8 Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire 5/8 ArriVent BioPharma Reports First Quarter 2024 Financial Results
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/7 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/6 Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire 5/2 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 5/2 Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...